Grufity logoGrufity logo

Viatris Inc Stock Research

VTRS

9.50USD0.00(0.00%)Market Closed

Market Summary

USD9.500.00
Market Closed
0.00%

VTRS Alerts

VTRS Stock Price

VTRS RSI Chart

VTRS Valuation

Market Cap

11.5B

Price/Earnings (Trailing)

5.54

Price/Sales (Trailing)

0.71

EV/EBITDA

1.59

Price/Free Cashflow

4.52

VTRS Price/Sales (Trailing)

VTRS Profitability

EBT Margin

17.35%

Return on Equity

9.86%

Return on Assets

4.16%

Free Cashflow Yield

22.11%

VTRS Fundamentals

VTRS Revenue

Revenue (TTM)

16.2B

Revenue Y/Y

-10.72%

Revenue Q/Q

-4.92%

VTRS Earnings

Earnings (TTM)

2.1B

Earnings Y/Y

483.32%

Earnings Q/Q

185.41%

Price Action

52 Week Range

8.3312.40
(Low)(High)

Last 7 days

-10.0%

Last 30 days

-20.7%

Last 90 days

-14.7%

Trailing 12 Months

-1.4%

VTRS Financial Health

Current Ratio

1.58

VTRS Investor Care

Dividend Yield

5.05%

Dividend/Share (TTM)

0.48

Shares Dilution (1Y)

0.26%

Diluted EPS (TTM)

1.71

Peers (Alternatives to Viatris)

View All Peers In Detail
NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
2.5T
387.5B
-0.56% -0.91%
25.94
6.37
2.44% -5.35%
2.1T
204.1B
-1.92% -6.89%
30.5
10.08
10.38% -5.25%
1.3T
282.8B
1.63% -25.54%
21.65
4.59
9.78% -21.12%
1.0T
514.0B
-3.36% -34.72%
-376.42
1.99
9.40% -108.16%
MID-CAP
3.6B
258.4M
203.99% 176.76%
-11.9
13.75
24.91% -254.56%
2.3B
9.2B
-18.97% -49.38%
-6.41
0.25
51.67% -98.90%
SMALL-CAP
1.7B
1.7B
-22.36% -14.62%
13.72
0.97
61.79% 371.82%
1.6B
602.5M
-17.77% -52.80%
-2.74
2.63
18.18% -18.59%
1.1B
418.9M
5.51% -56.16%
-2.93
2.57
-9.85% -101.06%
991.7M
478.9M
-11.35% -65.42%
-0.32
2.07
-31.50% -634.70%
954.9M
482.4M
-16.25% -37.64%
-4.12
1.98
33.15% -170.42%
897.6M
50.8M
-34.66% -77.56%
-1.14
17.66
1229.98% -13.59%
788.4M
1.1B
-10.56% -33.33%
27.33
0.72
-5.82% -92.23%
281.8M
10.3M
-24.84% -63.38%
-1.01
27.46
478.23% 7.85%

Financials for Viatris

Income Statement (Last 12 Months)
(In Millions)
* denotes actual numbers (not divided by Millions)
Description(%) Q/Q2022Q42022Q32022Q22022Q12021Q4
Revenue-2.8%16,21816,68217,13517,59217,814
Gross Profit-4.0%6,4976,7696,5956,2195,576
Operating Expenses-3.0%4,8825,0315,0595,2805,610
  S&GA Expenses4.6%4,1793,9974,0344,2584,529
  R&D Expenses3.1%747724709751-
EBITDA38.6%6,4334,6424,7304,738-
EBITDA Margin42.6%0.40*0.28*0.28*0.27*-
Earnings Before Taxes146.7%2,8131,140913304-664
EBT Margin153.7%0.17*0.07*0.05*0.02*-
Interest Expenses-0.2%592594592613636
Net Income158.7%2,079804761168-1,269
Net Income Margin166.1%0.13*0.05*0.04*0.01*-
Free Cahsflow-11.7%2,5472,8833,0832,834-
Balance Sheet
(In Millions)
* denotes actual numbers (not divided by Millions)
Description(%) Q/Q2022Q42022Q32022Q22022Q12021Q4
Assets2.8%50,02248,66351,12553,46754,843
  Current Assets1.4%10,63510,48811,17711,74410,903
    Cash Equivalents94.8%1,260647665752701
  Inventory4.1%3,5203,3803,6133,7973,978
  Net PPE-0.5%3,0253,0393,0843,1503,189
  Goodwill3.7%10,42610,05510,52310,97912,114
Liabilities-1.8%28,95029,48031,32033,01934,350
  Current Liabilities3.4%6,7466,5217,6819,6439,884
.    Short Term Borrowings-100.0%-5001,0206551,493
    LT Debt, Current64.8%1,2597647682,6061,878
    LT Debt, Non Current-3.8%18,01518,72519,20618,76319,717
Shareholder's Equity9.9%21,07219,18219,80520,44820,493
  Retained Earnings20.0%5,1764,3134,1073,9423,689
  Additional Paid-In Capital0.2%18,64618,61718,58618,55518,536
Shares Outstanding0.0%1,2131,2121,211--
Cashflow (Last 12 Months)
(In Millions)
Description(%) Q/Q2022Q42022Q32022Q22022Q12021Q4
Cashflow From Operations-11.4%2,9533,3333,5503,3073,017
  Share Based Compensation6.5%116109105107111
Cashflow From Investing414.7%1,521-483-486-421-117
Cashflow From Financing-33.9%-3,877-2,896-3,015-2,921-3,012

Risks for VTRS

What is the probability of a big loss on VTRS?

100%


Probability that Viatris stock will be more than 20% underwater in next one year

72.3%


Probability that Viatris stock will be more than 30% underwater in next one year.

30%


Probability that Viatris stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does VTRS drawdown profile look like?

Y-axis is the maximum loss one would have experienced if Viatris was unfortunately bought at previous high price.

Drawdowns

Returns for VTRS

Cumulative Returns on VTRS

-10.4%


10-Year Cumulative Returns

-19.5%


7-Year Cumulative Returns

-24.7%


5-Year Cumulative Returns

-12.4%


3-Year Cumulative Returns

What are the long-term rolling returns for VTRS?

FIve years rolling returns for Viatris.

Annualized Returns

Which funds bought or sold VTRS recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
2023-03-15
B. Riley Wealth Advisors, Inc.
added
18.18
165,615
472,615
0.01%
2023-03-10
VICTORY CAPITAL MANAGEMENT INC
added
31.97
12,651,000
30,126,000
0.03%
2023-03-10
MATHER GROUP, LLC.
new
-
132,814
132,814
-%
2023-03-06
Rockefeller Capital Management L.P.
reduced
-12.2
42,000
326,000
-%
2023-03-06
BIRMINGHAM CAPITAL MANAGEMENT CO INC/AL
added
13.3
342,321
1,053,320
0.40%
2023-03-03
TIAA, FSB
added
17.81
73,890
209,890
-%
2023-03-02
LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA
new
-
51,943
51,943
-%
2023-03-02
OLIVER LAGORE VANVALIN INVESTMENT GROUP
reduced
-80.7
124
124
-%
2023-03-01
Lakewood Asset Management LLC
new
-
5,000
5,000
-%
2023-02-28
Voya Investment Management LLC
added
4.58
1,309,940
4,886,940
0.01%

1–10 of 45

Latest Funds Activity

Are funds buying VTRS calls or puts?
Calls
Puts
Are funds bullish or bearish(Calls - Puts)?
Net Call Options
No. of funds that own VTRS
No. of Funds

Viatris News

Best Stocks

Accelerating Gene Therapy Development in the US through ....

Best Stocks,
16 hours ago

The Motley Fool

Is Viatris' 5% Dividend Yield Safe?.

The Motley Fool,
21 hours ago

StockNews.com

BNN Bloomberg

The Motley Fool

Schedule 13G FIlings of Viatris

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 09, 2023
vanguard group inc
12.31%
149,318,666
SC 13G/A
Feb 07, 2023
state street corp
5.10%
61,903,672
SC 13G
Jan 31, 2023
blackrock inc.
7.7%
93,214,306
SC 13G/A
Feb 04, 2022
wellington management group llp
4.57%
55,233,099
SC 13G/A
Feb 03, 2022
blackrock inc.
7.2%
86,554,658
SC 13G/A
Feb 04, 2021
wellington management group llp
5.74%
69,811,210
SC 13G
Feb 02, 2021
blackrock inc.
7.3%
89,526,414
SC 13G
Jan 08, 2021
vanguard group inc
10.62%
129,072,141
SC 13G

VTRS Fair Value

Viatris fair value in different scenarios

The table shows the Fair Value estimates for Viatris for various scenarios. Disclaimer: These are just estimations from a model. None of the models are good at predicting the future. Please dont buy or sell stocks based on these outputs.
Fair ValueVery PessimisticPessimisticBase CaseOptimisticVery Optimistic
Very Low Inflation

-

-

-

-

-

-

-

-

-

-
Current Inflation

4.11

-56.74%

5.02

-47.16%

6.82

-28.21%

9.68

1.89%

13.11

38.00%
Very High Inflation

-

-

-

-

-

-

-

-

-

-

Historical Viatris Fair Value Estimates


Very Pessimistic Case
Pessimistic Case
Fair Value
Optimistic Case
Very Optimistic Case
Closing Stock Price

Recent SEC filings of Viatris

View All Filings
Date Filed Form Type Document
Mar 06, 2023
4
Insider Trading
Mar 06, 2023
4
Insider Trading
Mar 06, 2023
4
Insider Trading
Mar 06, 2023
4
Insider Trading
Mar 06, 2023
4
Insider Trading
Mar 06, 2023
4
Insider Trading
Mar 06, 2023
4
Insider Trading
Mar 06, 2023
4
Insider Trading
Mar 06, 2023
4
Insider Trading
Mar 06, 2023
4
Insider Trading

Latest Insider Trading transactions for VTRS

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
2023-03-06
Ni Xiangyang (Sean)
sold
-34,890
11.0835
-3,148
president, greater china
2023-03-04
Cuneo Andrew
acquired
-
-
6,518
see remarks
2023-03-04
Campbell Paul
acquired
-
-
18,515
see remarks
2023-03-04
PARRISH MARK W
acquired
-
-
20,313
-
2023-03-04
Lyons Dillon JoEllen
acquired
-
-
20,313
-
2023-03-04
van der Meer Mohr Pauline
sold (taxes)
-6,800
11.13
-611
-
2023-03-04
van der Meer Mohr Pauline
acquired
-
-
20,313
-
2023-03-04
Mauro Anthony
acquired
-
-
37,917
see remarks
2023-03-04
GOETTLER MICHAEL
acquired
-
-
107,827
chief executive officer
2023-03-04
GOETTLER MICHAEL
sold (taxes)
-525,425
11.13
-47,208
chief executive officer

1–10 of 50

Michael Goettler
37000
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, including noncommunicable and infectious diseases; biosimilars in the areas of oncology, immunology, endocrinology, ophthalmology, and dermatology; and APIs for antibacterial, central nervous system agents, antihistamines/antiasthmatics, cardiovascular, antivirals, antidiabetics, antifungals, and proton pump inhibitor areas, as well as support services, such as diagnostic clinics, educational seminars, and digital tools to help patients better manage their health. It provides its medicines in the form of oral solid doses, injectables, complex dosage forms, and APIs to retail and pharmacy establishments, wholesalers and distributors, payers, insurers and governments, and institutions. The company distributes its products through pharmaceutical wholesalers/distributors, pharmaceutical retailers, institutional pharmacies, mail-order and e-commerce pharmacies, and specialty pharmacies. It sells its products under the Lyrica, Lipitor, Creon, Influvac, Wixela Inhub, EpiPen auto-injector, Fraxiparine, and Yupelri; Norvasc and Viagra; AMITIZA, Lipacreon, and Effexor; and Celebrex and ARV names, as well as offers biosimilars franchises, including Fulphila, Ogivri, Hulio, and SEMGLEE. The company has collaboration and licensing agreements with Revance Therapeutics, Inc.; Momenta Pharmaceuticals, Inc.; Theravance Biopharma, Inc.; Biocon Ltd.; and Fujifilm Kyowa Kirin Biologics Co. Ltd. Viatris Inc. was founded in 1961 and is headquartered in Canonsburg, Pennsylvania.

VTRS Income Statement

2022-12-31
Consolidated Statements of Operations - USD ($)
shares in Millions, $ in Millions
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Revenues:   
Net sales$ 16,218.1$ 17,813.6$ 11,819.9
Total revenues16,262.717,886.311,946.0
Cost of sales9,765.712,310.88,149.3
Gross profit6,497.05,575.53,796.7
Operating expenses:   
Research and Development Expense662.2681.0512.6
Acquired IPR&D36.470.142.5
Selling, general and administrative4,179.14,529.23,344.6
Litigation settlements and other contingencies, net4.4329.2107.8
Total operating expenses4,882.15,609.54,007.5
Earnings (loss) from operations1,614.9(34.0)(210.8)
Interest expense592.4636.2497.8
Other (income) expense, net(1,790.7)(5.8)12.6
Earnings (loss) before income taxes2,813.2(664.4)(721.2)
Income tax provision (benefit)734.6604.7(51.3)
Net earnings (loss)$ 2,078.6$ (1,269.1)$ (669.9)
Earnings (loss) per share attributable to Viatris Inc. shareholders   
Basic (in USD per share)$ 1.71$ (1.05)$ (1.11)
Diluted (in USD per share)$ 1.71$ (1.05)$ (1.11)
Weighted average shares outstanding:   
Basic (in shares)1,212.11,208.8601.2
Diluted (in shares)1,217.41,208.8601.2
Net sales   
Revenues:   
Net sales$ 16,218.1$ 17,813.6$ 11,819.9
Other revenues   
Revenues:   
Other revenues$ 44.6$ 72.7$ 126.1

VTRS Balance Sheet

2022-12-31
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Current assets:  
Cash and cash equivalents$ 1,259,900$ 701,200
Accounts receivable, net3,814,5004,266,400
Inventories3,519,5003,977,700
Prepaid expenses and other current assets1,811,2001,957,600
Assets held for sale230,3000
Total current assets10,635,40010,902,900
Property, plant and equipment, net3,024,5003,188,600
Intangible assets, net22,607,10026,134,200
Goodwill10,425,80012,113,700
Deferred income tax benefit925,9001,332,700
Other assets2,403,5001,170,700
Total assets50,022,20054,842,800
Current liabilities:  
Accounts payable1,766,6001,657,400
Short-term borrowings01,493,000
Income taxes payable279,600236,900
Current portion of long-term debt and other long-term obligations1,259,1001,877,500
Other current liabilities3,440,9004,619,600
Total current liabilities6,746,2009,884,400
Long-term debt18,015,20019,717,100
Deferred income tax liability2,432,0002,815,000
Other long-term obligations1,756,5001,933,600
Total liabilities28,949,90034,350,100
Viatris Inc. shareholders’ equity  
Common stock: $0.01 par value, 3,000,000,000 shares authorized; shares issued and outstanding: 1,213,793,231 and 1,209,507,463, respectively12,10012,100
Additional paid-in capital18,645,80018,536,100
Retained earnings5,175,6003,688,800
Accumulated other comprehensive loss(2,761,200)(1,744,300)
Total equity21,072,30020,492,700
Total liabilities and equity$ 50,022,200$ 54,842,800